Clinical features, risk factors, and outcome of carbapenem-resistant Acinetobacter baumannii bacteremia in a Thai neonatal intensive care unit

1. Chan PC, Huang LM, Lin HC, Chang LY, Chen ML, Lu CY. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2007; 28:423-9.10.1086/513120Search in Google Scholar

2. McGrath EJ, Chopra T, Abdel-Haq N, Preney K, Koo W, Asmar BI, et al. An outbreak of carbapenemresistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol. 2011; 32: 34-41.10.1086/657669Search in Google Scholar

3. Mittal N, Nair D, Gupta N, Rawat D, Kabra S, Kumar S, et al. Outbreak of Acinetobacter spp septicemia in a neonatal ICU. Southeast Asian J Trop Med Heath. 2003; 34:365-6.Search in Google Scholar

4. Huang YC, Su LH, Wu TL, Leu HS, Hsieh WS, Chang TM, et al. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive case unit: clinical implications and genotyping analysis.Search in Google Scholar

Pediatr Infect Dis J. 2002; 21:1105-9.12488658Search in Google Scholar

5. Manzar S. Outbreak of multidrug resistant Acinetobacter in the neonatal intensive care unit.Search in Google Scholar

Saudi Med J. 2004; 25:961-3.1523571110.1017/S0195941700080929Search in Google Scholar

6. Chang PY, Hsueh PR, Wu PS, Chan PC, Yang TT, Lu CY, et al. Muldrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan. J Microbiol Immunol Infect. 2007; 40: 406-10.Search in Google Scholar

7. Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, et al. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection. 2010; 38:173-80.10.1007/s15010-010-0008-1Open DOISearch in Google Scholar

8. Kuo LC, Yu CJ, Lee LN, Wang JL, Wang HC, Hsueh PR, et al. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc. 2003; 102: 601-6.Search in Google Scholar

9. Higgins PG, Dammhayn C, Hackel M, Seifert H.Search in Google Scholar

Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2010; 65:233-8.10.1093/jac/dkp428Search in Google Scholar

10. Le Hello S, Falcot V, Lacassin F, Mikulski M, Baumann F. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific. Scand J Infect Dis 2010; 42:821-6.10.3109/00365548.2010.496087Open DOISearch in Google Scholar

11. CLSI. Performance standards for antimicrobial disk susceptibility testing: twentieth information supplement. CLSI document M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.Search in Google Scholar

12. Drews MB, Ludwig AC, Leititist JU, Daschner FD.Search in Google Scholar

Low birth weight and nosocomial infection of neonates in a neonatal intensive care unit. J Hosp Infect. 1995; 30:65-72.10.1016/0195-6701(95)90250-3Search in Google Scholar

13. Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii. Am J Infect Control. 2002; 30:386-90.10.1067/mic.2002.12264812410214Open DOISearch in Google Scholar

14. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States.Search in Google Scholar

National Nosocomial Infections Surveillance System.Search in Google Scholar

Pediatrics. 1996; 98:357-61.8784356Search in Google Scholar

15. Cohen-Wolkowiez M, Moran C, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr, et al. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J. 2009; 28:1052-6.10.1097/INF.0b013e3181acf6bdOpen DOISearch in Google Scholar

16. Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V. Colistin administration to pediatric and neonatal patients. Eur J Pediatr. 2010; 169:867-74.10.1007/s00431-009-1137-320119725Search in Google Scholar

17. Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Nakwan N, et al. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.Search in Google Scholar

Pediatr Pulmol. 2011; 46:60-6.10.1365/s35127-011-0135-8Search in Google Scholar

18. Tiengrim S, Tribuddharat C, Thamlikitkul V. In vitro activity of tigecycline against clinical isolates of multi-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand. J Med Assoc Thai. 2006; 89: S102-S105.Search in Google Scholar

19. Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME. Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother. 2008; 62:45-55.10.1093/jac/dkn165805730418436554Open DOISearch in Google Scholar